Lv31
352 积分 2022-04-06 加入
Bispecific T cell engager therapy for refractory rheumatoid arthritis
3小时前
已完结
The immunology of rheumatoid arthritis
2天前
已完结
Mechanisms involved in triggering rheumatoid arthritis
4天前
已完结
Pathogenetic insights from the treatment of rheumatoid arthritis
4天前
已完结
A novel interleukin-10 antibody graft to treat inflammatory bowel disease
4天前
已完结
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
1个月前
已完结
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
1个月前
已完结
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
1个月前
已完结
Manipulating IL-10 signalling blockade for better immunotherapy
1个月前
已完结
Preclinical Safety Evaluation of Recombinant Human Interleukin-10
1个月前
已完结
皖公网安备34019202002308
